§ 872.3930. Bone grafting material.
170 words·~1 min read·
/us/cfr/t21/s§ 872.3930·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
(a)Identification. Bone grafting material is a material such as hydroxyapatite, tricalcium phosphate, polylactic and polyglycolic acids, or collagen, that is intended to fill, augment, or reconstruct periodontal or bony defects of the oral and maxillofacial region.
(b)Classification.
(1)Class II (special controls) for bone grafting materials that do not contain a drug that is a therapeutic biologic. The special control is FDA's “Class II Special Controls Guidance Document: Dental Bone Grafting Material Devices.” (See § 872.1(e) for the availability of this guidance document.)
(2)Class III (premarket approval) for bone grafting materials that contain a drug that is a therapeutic biologic. Bone grafting materials that contain a drug that is a therapeutic biologic, such as biological response modifiers, require premarket approval.
(c)Date premarket approval application
(PMA)or notice of product development protocol
(PDP)is required. Devices described in paragraph (b)(2) of this section shall have an approved PMA or a declared completed PDP in effect before being placed in commercial distribution. [70 FR 21949, Apr. 28, 2005]
Connections3 cite this
Cited by 3 sections
Citation graph
cites case law
§ 872.3930
Bone grafting material.
Fed. Reg.×3
Cites 0Cited by 3 across 1 source